Atezolimab İlişkili Ensefalopati
References
Pardoll D.M. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer. 2012;12:252–264
Satake T, Maruki Y, Kubo Y. Atezolizumab-induced Encephalitis in a Patient with Hepatocellular Carcinoma: A Case Report and Literature Review. Intern Med.2022; 61: 2619–2623.
Ibrahim EY, Zhao WC, Mapuru HH and et al. Hope, Cure and Adverse Effects in Immunotherapy: Atezolizumab-Associated Encephalitis in Metastatic Small Cell Lung Cancer-A Case Report and Literature Review. Case Reports in Neurology, 2022, 14:366-371
Satake T, Maruki Y, Kubo Y. Atezolizumab-induced Encephalitis in a Patient with Hepatocellular Carcinoma: A Case Report and Literature Review. Intern Med.2022; 61: 2619–2623.
Ibrahim EY, Zhao WC, Mapuru HH and et al. Hope, Cure and Adverse Effects in Immunotherapy: Atezolizumab-Associated Encephalitis in Metastatic Small Cell Lung Cancer-A Case Report and Literature Review. Case Reports in Neurology, 2022, 14:366-371
Pages
165-168
Published
June 14, 2024
Copyright (c) 2024 Academician Publishing Book Portal
License
LicenseHow to Cite
1.
Yıldız G. Atezolimab İlişkili Ensefalopati. In: Bıçakcı Ş, Demir T, Bıçakcı YK, editors. Olgularla Nörolojik Yoğun Bakım [Internet]. Türkiye: Academician Publishing Book DOI Portal; 2024 [cited 2026 Jul. 12]. pp. 165-8. Available from: https://omp35.books.akademisyen.net/index.php/akya/catalog/book/3085/chapter/13024
